The shares do not automatically dilute.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On 14 November 2012, Amarantus Biosciences, Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation, as amended, effecting an increase in the total number of authorized common shares of the Company from 250,000,000 to 1,000,000,000.